Accovion continues expansions across Europe

By Zachary Brennan

- Last updated on GMT

The company most recently established a subsidiary in Italy.
The company most recently established a subsidiary in Italy.

Related tags Eastern europe European union Europe

Germany-based full-service CRO (contract research organization) Accovion has expanded European presence with new offices in Italy, France and Eastern Europe. 

The company, which has a presence in more than 20 countries worldwide, announced the establishment of a subsidiary in Milan, Italy, which will be headed by Verónica de Lázaro. De Lázaro brings to Italy experience from successfully managing the company's Spanish operations. In addition to the space in Italy, and in line with the strategic plans for growth throughout Europe, a new subsidiary in Lyon, France, is also slated to open early this fall.

The expansions come more than three years after the company opened another subsidiary​ in England, as well as similar subsidiaries in Russia and the Czech Republic.

Ivana Waller, COO of Accovion, said: "In addition to further strengthening our local presence in Western Europe, we will focus on future growth in Eastern Europe.”

To help facilitate that growth, Accovion named Łukasz Sobiak  as the Regional Director of Clinical Operations for Eastern and South-Eastern Europe as well as the Country Director of Accovion Poland. “Dr. Sobiak's responsibilities will include further development of Accovion's capabilities in Eastern Europe, including Ukraine and the Baltic region​," Waller said.

Back-End Services

In parallel to its international strategy, Accovion recently re-adjusted its German back-end service capacities. This streamlining effort helps to improve Accovion's overall resource utilization and increases its agility.

"All the forward-focused, dynamic actions undertaken this year put us in a strong position to become the market leader amongst independent European CROs. We aim to offer our clients a broad spectrum of country-specific clinical research expertise providing the high quality front-end and back-end services that Accovion is known for​," said Andree Beckerling, the CEO of Accovion.

Formed in 2002, the Frankfurt-based company was created via clinical research, pharmacovigilance and medical writing assets at Aventis​.

Related news

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more